Search Torrents
|
Browse Torrents
|
48 Hour Uploads
|
TV shows
|
Music
|
Top 100
Audio
Video
Applications
Games
Porn
Other
All
Music
Audio books
Sound clips
FLAC
Other
Movies
Movies DVDR
Music videos
Movie clips
TV shows
Handheld
HD - Movies
HD - TV shows
3D
Other
Windows
Mac
UNIX
Handheld
IOS (iPad/iPhone)
Android
Other OS
PC
Mac
PSx
XBOX360
Wii
Handheld
IOS (iPad/iPhone)
Android
Other
Movies
Movies DVDR
Pictures
Games
HD - Movies
Movie clips
Other
E-books
Comics
Pictures
Covers
Physibles
Other
Details for:
Nature Reviews Drug Discovery - March 2012[Team Nanban][TPB]
nature reviews drug discovery march 2012 team nanban tpb
Type:
E-books
Files:
3
Size:
3.7 MB
Uploaded On:
April 11, 2012, 11:09 a.m.
Added By:
594mgnav
Seeders:
0
Leechers:
1
Info Hash:
341A0F9ABC361FE6378DC2AF754DEB5740C9E063
Get This Torrent
Nature Reviews Drug Discovery - March 2012[Team Nanban][TPB] English | True PDF | 85 pages | 4 MB DESCRIPTION: The number of new drugs approved per billion US dollars invested in research and development (R&D) has declined progressively in the past 60 years, despite improvements in scientific and technological inputs into the R&D process. Given the apparent lack of impact so far of many solutions to this decline in R&D efficiency, Scannell and colleagues question whether the underlying problems have been correctly diagnosed and discuss factors they consider to be responsible, with the aim of stimulating further systematic analysis. It is anticipated that the use of biomarkers to match the right drug to the right patient is one strategy that could reduce the size, failure rates and cost of clinical trials. In their Perspective article, Kelloff and Sigman highlight the biomarkers expressed during cancer development and progression, focusing on those that are most relevant for identifying patients who are likely to respond to a specific therapy, and those that are most effective for measuring patient response. The design of biomarker-based cancer clinical trials and the associated challenges are considered. Accumulating evidence suggests that indicators of immune system activity in cancer patients can also be of prognostic value or be used to predict treatment response. This is discussed by Galluzzi and colleagues, who review the cellular and molecular mechanisms by which current anticancer agents can activate the immune system against cancer, and their therapeutic implications. Inappropriate immune system activation has a key role in chronic inflammatory disorders, a common feature of which is bone loss. Redlich and Smolen review them mechanisms mediating bone loss in such disorders, and discuss current and emerging counteractive therapeutic strategies. PLZ SEED AFTER DOWNLOADING... "SHARING IS CARING"
Get This Torrent
Filelist not found
0 bytes
